Top Stock to Buy #2 – Pfizer (PFE)
Pfizer (NYSE:PFE) is the world’s largest pharmaceutical company producing a wide range of drugs. In October 2009, it acquired Wyeth.
The stock has a long history of earnings improvements that have resulted in increasing dividends. The current dividend yield is 3.98%. Analysts have raised their price target to $26-$28.
Technically PFE is in danger of breaking a small head-and-shoulders pattern neckline at just under $22. This should be a cornerstone pharmaceutical stock in long-term portfolios. Thus a pullback to under $20.50 would be a bargain. Buy for long-term accounts.
Comments are currently unavailable. Please check back soon.